Neuland Laboratories Community

BSE:524558 Community

1 Narratives written by author
0 Comments on narratives written by author
6 Fair Values set on narratives written by author

Neuland Laboratories

AN

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Enhancing Peptide Capacity Will Tap Into Expanding Market For Peptide Therapies

Key Takeaways Strategic investments in capital expenditure and peptide capacity aim to boost future revenues, profitability, and operational margins. Focus on high-value and complex chemistry positions Neuland for higher-margin opportunities and revenue growth from FY '26 onwards.

₹17.60k

FV

30.1% undervalued

25.59%

Revenue growth p.a.

1

0

3

3 days ago